• 已选条件：
  • × BMC Clinical Pharmacolog
  • × Type 2 Diabetes
 全选  【符合条件的数据共：2条】

1 A novel 11β-hydroxysteroid dehydrogenase type1 inhibitor CNX-010-49 improves hyperglycemia, lipid profile and reduces body weight in diet induced obese C57B6/J mice with a potential to provide cardio protective benefits [期刊论文]

来源：BMC Clinical Pharmacology

作者:Baggavalli P Somesh;Madanahalli R Jagannath;Marikunte V Venkataranganna;等

关键词:Cardiovascular risks;Type 2 Diabetes;...

预览  |  原文链接  |  全文  [ 浏览：3 下载：0  ]    

2 A novel 11β-hydroxysteroid dehydrogenase type1 inhibitor CNX-010-49 improves hyperglycemia, lipid profile and reduces body weight in diet induced obese C57B6/J mice with a potential to provide cardio protective benefits [期刊论文]

来源：BMC Clinical Pharmacology

作者:Baggavalli P Somesh;Madanahalli R Jagannath;Marikunte V Venkataranganna;等

关键词:Cardiovascular risks;Type 2 Diabetes;...

预览  |  原文链接  |  全文  [ 浏览：2 下载：0  ]